XML 126 R69.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Collaboration and Licensing Revenue - Summarized Collaboration and Licensing Revenues (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues $ 90,722 $ 151,178 $ 219,463
Collaboration and licensing agreements      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues 14,059 69,540 134,624
ZIOPHARM Oncology, Inc. | Collaboration and licensing agreements      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues 2,171 16,298 69,812
Ares Trading S.A. | Collaboration and licensing agreements      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues 0 11,175 10,738
Oragenics, Inc. | Collaboration and licensing agreements      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues (564) 1,353 1,469
Intrexon T1D Partners, LLC | Collaboration and licensing agreements      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues 0 2,502 5,968
Intrexon Energy Partners, LLC | Collaboration and licensing agreements      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues 2,596 6,929 10,665
Intrexon Energy Partners II, LLC | Collaboration and licensing agreements      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues 1,217 2,998 3,672
Fibrocell Science, Inc. | Collaboration and licensing agreements      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues 3,713 1,394 7,344
OvaXon, LLC | Collaboration and licensing agreements      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues 0 0 1,966
S & I Ophthalmic, LLC | Collaboration and licensing agreements      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues 0 0 755
Harvest Start-Up Entities | Collaboration and licensing agreements      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues [1] 4,862 14,447 15,232
Other | Collaboration and licensing agreements      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues $ 64 $ 12,444 $ 7,003
[1]
For the years ended December 31, 2019, 2018, and 2017, revenue recognized from collaborations with Harvest start-up entities include Exotech Bio, Inc.; AD Skincare, Inc.; and Thrive Agrobiotics, Inc. For the years ended December 31, 2018 and 2017, revenue recognized from collaborations with Harvest start-up entities also include Genten Therapeutics
and CRS Bio. For the year ended December 31, 2017, revenue recognized from collaborations with Harvest start-up entities also include Relieve Genetics.